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Case Studies performed by IFA. All subsequent testing by ELISA showed mild elevation of IgM and negative IgG. Due to a lack of specificity of immunofluorescent testing and the subjective interpretation of results, it is unlikely that the IgG result was a true positive. This conclusion is supported by the negative IgG in all subsequent tests performed by different reference laboratories. False negative results due to high titers of IgG (prozone phenomenon) were excluded by testing multiple dilutions in 2 different laboratories. The original specimen was not available for repeat testing and all subsequent specimens were sent to reference laboratories since serology services had been discontinued in our hospital laboratory. Typically, IgG antibodies appear within 1 to 2 weeks of infection, peak within 1 to 2 months, decline at variable rates, and persist for life. 1, 2 In this case, the IgM was mildly elevated in all of the specimens. Since the IgG and DNA PCR were negative and the patient lacked any clinical manifestations of toxoplasmosis, it is likely that the IgM result was a false positive. IgM titers become negative within a few months after an acute infection. However, in some patients, positive IgM titers persist for 1 year or even longer. 1 2. The false positive rate of T. gondii IgM testing can be as high as 60%. 2 The high sensitivity and negative predictive value of this assay, however, make it a good test to exclude toxoplasmosis when the result is negative. False-positive IgM can be caused by autoimmune antibodies including rheumatoid factor and antinuclear antibodies, acute viral infection, and non-specific in vitro binding. 3 Serology testing for Toxoplasma IgM may be difficult to interpret, especially in immunocompromised patients and in patients who do not display signs or symptoms of the infection. The specific reason for the false-positive IgM in this patient could not be determined. In 1997, the Food and Drug Administration issued an advisory concerning the limitations of T. gondii testing. 
Figure 1
Algorithm for the serodiagnosis of toxoplasmosis in people older than 1 year of age.
in 2-3 weeks remains positive for IgG, acute infection is suspected, but if IgG is still negative, false positive IgM is more likely. 5, 6 If testing is performed in local laboratories, specimens should be submitted to a reference laboratory for confirmation. IgG avidity testing to distinguish recent from past infections and T. gondii DNA PCR may be necessary in some situations. 4 . In transplant patients, severe or disseminated toxoplasmosis can result either from a reactivation of latent infection in the recipient or infection from a cyst-containing organ from the donor. 1 Reactivation of chronic infection may occur in the recipient regardless of the type of the allograft (D-/R+ or D+/R+), but the risk is closely related to the type and duration of immunosuppression and it is higher in patients receiving hematopoietic stem cell or liver transplants.
1,2 A seropositive donor (D+) and seronegative recipient (R-) represent the highest risk for disease in heart, lung, heart and lung combined, and kidney transplant recipients.
1,2 Trimethoprim/sulfamethoxazole prophylaxis is highly effective in these patients. Recipients in D-/R-, D-/R+, or D+/R+ scenarios rarely develop toxoplasmosis. 2 5. Patients with false positive Toxoplasma serology may undergo unnecessary and potentially dangerous treatment and procedures. This patient experienced significant consequences from the false positive lab results: entry to the lung transplant list was delayed, and the patient received unnecessary medications, gave away his pets, and underwent numerous additional laboratory studies and office visits. Before any intervention, healthcare professionals should follow the published guidelines for diagnosing toxoplasmosis and should confirm the results by a reference laboratory. LM
